- Filed
- Nov 10, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2021 · Sep 30, 2021 | 46.57K sh |
| Shares Diluted | Q3 2021 · Sep 30, 2021 | 78.76K sh |
| Capex | Q3 2021 · Sep 30, 2021 | $628K |
| Capex | Q3 2021 · Sep 30, 2020 | $11K |
| Operating Cash Flow | Q3 2021 · Sep 30, 2021 | −$29.51M |
| Operating Cash Flow restated | Q3 2021 · Sep 30, 2020 | $24.43M |
| Long Term Debt | Q3 2021 · Sep 30, 2021 | $134.2M |
| Long Term Debt | Q3 2021 · Dec 31, 2020 | $141.73M |
| Short Term Debt | Q3 2021 · Sep 30, 2021 | $397K |
| Cash And Equivalents | Q3 2021 · Sep 30, 2021 | $134.37M |
| Cash And Equivalents | Q3 2021 · Dec 31, 2020 | $77.86M |
| Cash And Equivalents restated | Q3 2021 · Sep 30, 2020 | $3.61M |
| Stockholders Equity | Q3 2021 · Sep 30, 2021 | −$595.34M |
| Stockholders Equity | Q3 2021 · Jun 30, 2021 | −$421.43M |
| Stockholders Equity | Q3 2021 · Dec 31, 2020 | −$866.18M |
| Stockholders Equity restated | Q3 2021 · Sep 30, 2020 | −$307.79M |
| Stockholders Equity restated | Q3 2021 · Jun 30, 2020 | −$299.2M |
| Stockholders Equity restated | Q3 2021 · Dec 31, 2019 | −$8.39M |
| Current Liabilities | Q3 2021 · Sep 30, 2021 | $110.11M |
| Current Liabilities | Q3 2021 · Dec 31, 2020 | $80.05M |
| Total Liabilities | Q3 2021 · Sep 30, 2021 | $334.41M |
| Total Liabilities | Q3 2021 · Dec 31, 2020 | $427.29M |
| Current Assets | Q3 2021 · Sep 30, 2021 | $217.01M |
| Current Assets | Q3 2021 · Dec 31, 2020 | $140.43M |
| Total Assets | Q3 2021 · Sep 30, 2021 | $288.96M |
| Total Assets | Q3 2021 · Dec 31, 2020 | $178.73M |
| Eps Diluted | Q3 2021 · Sep 30, 2021 | −$0.55 |
| Eps Diluted | Q3 2021 · Sep 30, 2021 | −$0.44 |
| Eps Basic | Q3 2021 · Sep 30, 2021 | −$0.55 |
| Eps Basic | Q3 2021 · Sep 30, 2021 | $1.18 |
| Net Income | Q3 2021 · Sep 30, 2021 | −$25.76M |
| Net Income | Q3 2021 · Sep 30, 2021 | $52.85M |
| Net Income restated | Q3 2021 · Sep 30, 2020 | −$1.77M |
| Net Income restated | Q3 2021 · Sep 30, 2020 | $2.51M |
| Operating Income | Q3 2021 · Sep 30, 2021 | −$8.68M |
| Operating Income | Q3 2021 · Sep 30, 2021 | −$21.47M |
| Operating Income restated | Q3 2021 · Sep 30, 2020 | $8.16M |
| Operating Income restated | Q3 2021 · Sep 30, 2020 | $22.51M |
| Cost Of Revenue | Q3 2021 · Sep 30, 2021 | $17.01M |
| Cost Of Revenue | Q3 2021 · Sep 30, 2021 | $43.87M |
| Cost Of Revenue | Q3 2021 · Sep 30, 2020 | $10.24M |
| Cost Of Revenue | Q3 2021 · Sep 30, 2020 | $26.93M |
| Revenue | Q3 2021 · Sep 30, 2021 | $35.64M |
| Revenue | Q3 2021 · Sep 30, 2021 | $94.08M |
| Revenue | Q3 2021 · Sep 30, 2020 | $25.93M |
| Revenue | Q3 2021 · Sep 30, 2020 | $68.09M |
| Dividends Paid | Q3 2021 · Sep 30, 2020 | $30.82M |